Clenbutaxyl 40 - Kalpa Pharmaceuticals

Developed to alleviate bronchospastic conditions, clenbuterol hydrochloride became internationally recognized for its long half-life and minimal cardiovascular stimulation. Its beta-2 selectivity was a defining feature that allowed it to treat asthma without the jittery effects common to earlier sympathomimetics. Despite global usage, clenbuterol was never introduced into the U.S. market for human patients, a gap that later gave rise to its underground reputation for metabolic enhancement and physique conditioning.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Clenbutaxyl 40 by Kalpa Pharmaceuticals, consult with your doctor or healthcare professional.